These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21555813)

  • 1. Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide.
    Dunn MC; Knight DA; Waldman WJ
    Antivir Ther; 2011; 16(3):309-17. PubMed ID: 21555813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.
    Chang JS; Wang KC; Shieh DE; Chiang LC
    J Ethnopharmacol; 2011 Oct; 137(3):1149-55. PubMed ID: 21810459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
    Li L; Yu CH; Ying HZ; Yu JM
    J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of respiratory syncytial virus in cultured cells by nucleocapsid gene targeted deoxyribozyme (DNAzyme).
    Xie YY; Zhao XD; Jiang LP; Liu HL; Wang LJ; Fang P; Shen KL; Xie ZD; Wu YP; Yang XQ
    Antiviral Res; 2006 Aug; 71(1):31-41. PubMed ID: 16687180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus disease: update on treatment and prevention.
    Krilov LR
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):27-32. PubMed ID: 21171875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antiviral efficacy against human respiratory syncytial virus using cotton rat and mouse models.
    Van den Berg J; Kwanten L; Roymans D
    Methods Mol Biol; 2013; 1030():365-72. PubMed ID: 23821282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
    Liu V; Dhillon GS; Weill D
    Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral efficacy of VP14637 against respiratory syncytial virus in vitro and in cotton rats following delivery by small droplet aerosol.
    Wyde PR; Laquerre S; Chetty SN; Gilbert BE; Nitz TJ; Pevear DC
    Antiviral Res; 2005 Oct; 68(1):18-26. PubMed ID: 16112208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of antiviral compounds on respiratory syncytial virus using a juvenile vervet monkey (Chlorocebus pygerythrus) infection model.
    Houspie L; Stevens H; Ngotho M; Keyaerts E; Ispas G; Verloes R; Van Ranst M; Maes P
    Methods Mol Biol; 2013; 1030():373-82. PubMed ID: 23821283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus infection in adults.
    Murata Y; Falsey AR
    Antivir Ther; 2007; 12(4 Pt B):659-70. PubMed ID: 17944273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapies for an old virus: treatment of RSV infections in the 21st Century.
    Lüsebrink J; Schildgen V; Schildgen O
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1125-9. PubMed ID: 19883332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection.
    van Woensel JB; Lutter R; Biezeveld M; Dekker T; Nijhuis M; van Aalderen WM; Kuijpers TW
    Pediatr Infect Dis J; 2003 Aug; 22(8):721-6. PubMed ID: 12913774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection.
    Blanco JC; Boukhvalova MS; Hemming P; Ottolini MG; Prince GA
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):945-55. PubMed ID: 16307507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
    Wendt CH; Hertz MI
    Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
    J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo.
    Miller AL; Bowlin TL; Lukacs NW
    J Infect Dis; 2004 Apr; 189(8):1419-30. PubMed ID: 15073679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.
    Wang KC; Chang JS; Lin LT; Chiang LC; Lin CC
    Am J Chin Med; 2012; 40(5):1033-45. PubMed ID: 22928833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel fusion inhibitors of human respiratory syncytial virus.
    Lundin A; Bergström T; Bendrioua L; Kann N; Adamiak B; Trybala E
    Antiviral Res; 2010 Dec; 88(3):317-24. PubMed ID: 20965215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus infections: recent prospects for control.
    Sidwell RW; Barnard DL
    Antiviral Res; 2006 Sep; 71(2-3):379-90. PubMed ID: 16806515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.